Expected Sample Clauses

Expected outcomes of the Workshops and Seminars including factors . which can cause the workshops, seninars and educational training programs to succeed or fail, the role of senior management and supporting requirements. . a . - ,~ , - - . ,-- _ . , .. , . .. . _. _ ._ _ _ . * . ., , " . ,. , I 'f~ * Contract' No. . NRC-10'-80-399 , . .Within.-fourteen (14) working days following the coi i outlining: outcomes of the workshops and seminars . .
Sample 1
Expected. The screen should not jitter or shake when using normal functions during replay mode.
Sample 1
Expected. Programme Results 3.1. Inception Report covering all BENEFICIARIES; 3.2. Water Safety Plan for each BENEFICIARY; 3.3. Long-term Investment Programmes for each BENEFICIARY; 3.4. Short-term Investment Programme for each BENEFICIARY; 3.5. Financial Model for each BENEFICIARY including projections at least for 30 years period; 3.6. Water Balance Report for each BENEFICIARY; 3.7. Non-Revenue Water (NRW) Management Plan for each BENEFICIARY; 3.8. Quarterly Progress Reports (starting after first six months has passed) describing the progress in each BENEFICIARY and summarising it for all BENEFICIARIES, including training records (lists of participants, copies of presentations); 3.9. Final Report for each BENEFICIARY; 3.10. Summary Final Report summarising all BENEFICIARIES. Стаття 3. Очікувані результати від реалізації Програми 3.1. Початковий звіт, що охоплює всіх БЕНЕФІЦІАРІВ; 3.2. План забезпечення безпечною водою для кожного міста БЕНЕФІЦІАРА; 3.3. Довгострокові інвестиційні програми для кожного БЕНЕФІЦІАРА; 3.4. Короткострокова інвестиційна програма для кожного БЕНЕФІЦІАРА; 3.5. Фінансова модель для кожного БЕНЕФІЦІАРА, зокрема, прогнози щонайменше на 30 років; 3.6. Звіт про водний баланс для кожного БЕНЕФІЦІАРА; 3.7. План управління бездохідною водою для кожного БЕНЕФІЦІАРА; 3.8. Щоквартальні звіти про хід виконання (починаючи після закінчення перших шести місяців), в яких описано хід виконання у кожного БЕНЕФІЦІАРА, та міститься узагальнення по всіх БЕНЕФІЦІАРАХ. Сюди входять дані про навчання (переліки учасників, копії презентацій); 3.9. Підсумковий звіт по кожному БЕНЕФІЦІАРУ; 3.10. Зведений підсумковий звіт, в якому надаються дані по всіх БЕНЕФІЦІАРАХ.
Sample 1
Expected. The teacher’s SLO was 65 to 85 percent attained.
Sample 1
Expected. The nature and severity of an event, associated with the use of an IMP, which is consistent with the applicable reference safety information (e.g., Investigator's Brochure or Development Core Safety Information for an unapproved IMP).
Sample 1
Expected. Frequency of Duration of --------------------------------------------------------------------------------------------------------- Type Scheduled Maintenance Inspection Inspection Major Combustion Inspection Every 400 starts or 8,000 equivalent hours 4-5 days ** Major Hot Gas Path Inspection Every 800 starts or 24,000 equivalent hours 10-12 days ** Major Major CT Overhaul Every 1,600 starts or 48,000 equivalent hours 20 days ** Routine* BOP Inspections Each Spring and Fall 4 days --------------------------------------------------------------------------------------------------------- ----------- * Routine Balance of Plant inspections will be scheduled during a Major Inspection outage. ** Assumes all parts are in stock at site. If required parts are not on site, Planned Outage time could be lengthened by as much as four times that indicated. APPENDIX L UNIT ONE-LINE DIAGRAM (DIAGRAM) UNIT 1 AND 2 TRUE UP (Covering the Period 3/1/2001 through the Engage Termination Date) Seller's Units 1 and 2 are currently under contract both between Seller and Engage Energy America, LLC ("Engage") as well as between Engage and Buyer (ostensibly Engage has purchased the exclusive rights for the off-take of these units from Seller and has in turn sold these rights to Buyer). Engage has appointed Buyer as its agent for Dispatch purposes under the Engage PSA. Commencing March 1, 2001 and until the Engage Termination Date, a pricing true up shall occur as described below (the "Unit 1 and 2 True Up") to provide Buyer with the same financial and operational arrangements for Units 1 and 2 that exist in this Agreement with regards to Units 3, 4, and 9. This Xxxx 0 and 2 True Up shall be made for each sequential month for the period commencing on March 1, 2001 and lasting until the Engage Termination Date. This True-Up will consist of comparing the pricing and operational parameters (taken primarily from the Engage PSA) listed below under "Base Case", with those outlined in this Agreement. Seller shall net the monthly billing for the below listed items (other than the Summer Availability Bonus/Penalty which will be netted prior to January 31 of the following year - see below) against the terms and conditions detailed in this Agreement and will then sum the aggregates. Buyer will be billed any obligations that might be owed to Seller upon completion of this summation and will be offset against any money owed to Seller. Beginning with the Engage Termination Date, Buyer's Units 1 and 2...
Sample 1

Related to Expected

  • Material Adverse Effect The occurrence of any event or condition that has had, or could reasonably be expected to have, a Material Adverse Effect.

  • Material Adverse Effects The occurrence of any act, omission, change or event which has a Material Adverse Effect, subsequent to the date of the most recent audited financial statements of the Borrower delivered to the Lender pursuant to Section 13.04;

  • No Adverse Effect The acquisition by the Collateral Agent of the Receivables arising in the Additional Accounts shall not, in the reasonable belief of the Trust, result in an Adverse Effect;

  • No Material Adverse Effect Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement and Prospectus, there has not been (i) any Material Adverse Effect, or any development that would result in a Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii) any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company or the Subsidiaries, which is material to the Company and the Subsidiaries taken as a whole, (iv) any material change in the capital stock (other than (A) the grant of additional options under the Company’s existing stock option plans, (B) changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, (C) as a result of the issuance of Placement Shares, (D) any repurchases of capital stock of the Company, (E) as described in a proxy statement filed on Schedule 14A or a Registration Statement on Form S-4, or (F) otherwise publicly announced) or outstanding long-term indebtedness of the Company or the Subsidiaries or (v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as otherwise disclosed in the Registration Statement or Prospectus (including any document incorporated by reference therein).

  • Parent Material Adverse Effect Since the date of this Agreement, there shall not have been any Parent Material Adverse Effect or any event, change, or effect that would, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect.

  • No Company Material Adverse Effect Since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect.

  • Notice of Material Adverse Effect The Company shall notify the Buyer (and any subsequent holder of the Debentures), as soon as practicable and in no event later than three (3) business days of the Company’s knowledge of any Material Adverse Effect on the Company. For purposes of the foregoing, “knowledge” means the earlier of the Company’s actual knowledge or the Company’s constructive knowledge upon due inquiry.

  • Absence of Material Adverse Effect Since the date of this Agreement, there shall not have been any event, change or occurrence that, individually or in the aggregate, has had or would reasonably be expected to have a Company Material Adverse Effect.

  • No Parent Material Adverse Effect Since the date of this Agreement, there shall not have occurred any Parent Material Adverse Effect.

  • Company Material Adverse Effect Since the date of this Agreement, there shall not have been any Company Material Adverse Effect or any event, change or effect that would, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect.